Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Elevated Nucleated Red Blood Cells in Neonates with Down Syndrome and Pulmonary Hypertension.

Nitzan I, Kasirer Y, Mimouni FB, Fink D, Wasserteil N, Hammerman C, Bin Nun A.

J Pediatr. 2019 Oct;213:232-234. doi: 10.1016/j.jpeds.2019.05.068. Epub 2019 Jun 28.

PMID:
31262527
2.

Head Circumference Growth Is Enhanced by SMOFlipid in Preterm Neonates.

Bin-Nun A, Kassirer Y, Mimouni FB, Shchors I, Hammerman C.

Am J Perinatol. 2019 Jun 5. doi: 10.1055/s-0039-1692390. [Epub ahead of print]

PMID:
31167235
3.

Trends in Drug Trial Publications Involving Neonates: Has the Legislation Helped?

Bin-Nun A, Hammerman C, Wasserteil N, Mimouni FB, Glatstein M, Scolnik D, Kasirer YM.

Am J Ther. 2019 Nov/Dec;26(6):e714-e716. doi: 10.1097/MJT.0000000000000972. No abstract available.

PMID:
31162156
4.

Upper Lip Tie and Breastfeeding: A Systematic Review.

Nakhash R, Wasserteil N, Mimouni FB, Kasirer YM, Hammerman C, Bin-Nun A.

Breastfeed Med. 2019 Mar;14(2):83-87. doi: 10.1089/bfm.2018.0174. Epub 2019 Jan 25.

PMID:
30681376
5.

Wide Pulse Pressure Is Not Associated with Patent Ductus Arteriosus in the First Week of Life.

Bin-Nun A, Kasirer Y, Mimouni F, Schorrs I, Fink D, Hammerman C.

Am J Perinatol. 2019 Nov;36(13):1401-1404. doi: 10.1055/s-0038-1677475. Epub 2019 Jan 15.

PMID:
30646420
6.

SMOFlipid Protects Preterm Neonates against Perinatal Nutrition-Associated Cholestasis.

Kasirer Y, Bin-Nun A, Raveh A, Schorrs I, Mimouni FB, Hammerman C.

Am J Perinatol. 2019 Nov;36(13):1382-1386. doi: 10.1055/s-0038-1676977. Epub 2019 Jan 8.

PMID:
30620942
7.

Effect of rewarming in oxygenation and respiratory condition after neonatal exposure to moderate therapeutic hypothermia.

Nitzan I, Goldberg S, Hammerman C, Bin-Nun A, Bromiker R.

Pediatr Neonatol. 2019 Aug;60(4):423-427. doi: 10.1016/j.pedneo.2018.10.001. Epub 2018 Oct 31.

8.

Ductus arteriosus outcome with focus on the initially patent but hemodynamically insignificant ductus in preterm neonates.

Fink D, Nitzan I, Bin-Nun A, Mimouni F, Hammerman C.

J Perinatol. 2018 Nov;38(11):1526-1531. doi: 10.1038/s41372-018-0204-x. Epub 2018 Aug 17.

PMID:
30120422
9.

The effect of patent ductus arteriosus on pre-ductal and post-ductal perfusion index in preterm neonates.

Nitzan I, Hammerman C, Fink D, Nitzan M, Koppel R, Bromiker R.

Physiol Meas. 2018 Jul 20;39(7):075006. doi: 10.1088/1361-6579/aacf25.

PMID:
29943734
10.

Might Bilirubin Serve as a Natural Antioxidant in Response to Neonatal Encephalopathy?

Bin-Nun A, Mimouni FB, Kasirer Y, Schors I, Schimmel MS, Kaplan M, Hammerman C.

Am J Perinatol. 2018 Sep;35(11):1107-1112. doi: 10.1055/s-0038-1641746. Epub 2018 Apr 10.

PMID:
29635653
11.

Paracetamol Serum Concentrations in Neonates Treated Enterally for Ductal Closure: A Pilot Study.

Bin-Nun A, Fink D, Mimouni FB, Algur N, Hammerman C.

J Pediatr. 2018 Jul;198:304-307. doi: 10.1016/j.jpeds.2018.01.024. Epub 2018 Mar 7.

PMID:
29525073
12.

Packed red blood cells transfusion in neonates: effect on FiO2 and PaO2/SaO2 ratio, and implications for neonatal saturation targeting.

Nitzan I, Hammerman C, Mimouni FB, Bin-Nun A.

J Perinatol. 2018 Jun;38(6):693-695. doi: 10.1038/s41372-018-0079-x. Epub 2018 Feb 21.

PMID:
29467516
13.

The mortality of very low birth weight infants: the benefit and relative impact of changes in population and therapeutic variables.

Grisaru-Granovsky S, Boyko V, Lerner-Geva L, Hammerman C, Rottenstreich M, Samueloff A, Schimmel MS, Reichman B; Israel Neonatal Network.

J Matern Fetal Neonatal Med. 2019 Aug;32(15):2443-2451. doi: 10.1080/14767058.2018.1438398. Epub 2018 Feb 20.

PMID:
29415590
14.

Use of Oxyhemoglobin Saturation or Oxygen Tension-An Unsolved Question.

Nitzan I, Mimouni FB, Hammerman C.

JAMA Pediatr. 2018 Apr 1;172(4):390. doi: 10.1001/jamapediatrics.2017.5522. No abstract available.

PMID:
29404574
15.

Tale of Two Patent Ductus Arteriosus Severity Scores: Similarities and Differences.

Fink D, El-Khuffash A, McNamara PJ, Nitzan I, Hammerman C.

Am J Perinatol. 2018 Jan;35(1):55-58. doi: 10.1055/s-0037-1605576. Epub 2017 Aug 8.

PMID:
28787748
16.

Heparinization of Long Indwelling Lines in Neonates: Systematic Review and Practical Recommendations.

Bin-Nun A, Wasserteil N, Nakhash R, Hammerman C.

Isr Med Assoc J. 2016 Nov;18(11):692-696. Review. No abstract available.

17.

Mandatory closure versus nonintervention for patent ductus arteriosus in very preterm infants.

Mimouni FB, Hammerman C.

J Pediatr. 2017 Mar;182:406. doi: 10.1016/j.jpeds.2016.11.009. Epub 2016 Nov 28. No abstract available.

PMID:
27908647
18.

Elevated Nucleated Red Blood Cells at Birth Predict Hemodynamically Significant Patent Ductus Arteriosus.

Bin-Nun A, Mimouni FB, Fink D, Sela H, Hammerman C.

J Pediatr. 2016 Oct;177:313-315. doi: 10.1016/j.jpeds.2016.07.005. Epub 2016 Aug 10.

PMID:
27522442
19.

The Preterm Infant: A High-Risk Situation for Neonatal Hyperbilirubinemia Due to Glucose-6-Phosphate Dehydrogenase Deficiency.

Kaplan M, Hammerman C, Bhutani VK.

Clin Perinatol. 2016 Jun;43(2):325-40. doi: 10.1016/j.clp.2016.01.008. Epub 2016 Feb 28. Review.

PMID:
27235211
20.

Paracetamol for the treatment of patent ductus arteriosus in preterm neonates: a systematic review and meta-analysis.

Terrin G, Conte F, Oncel MY, Scipione A, McNamara PJ, Simons S, Sinha R, Erdeve O, Tekgunduz KS, Dogan M, Kessel I, Hammerman C, Nadir E, Yurttutan S, Jasani B, Alan S, Manguso F, De Curtis M.

Arch Dis Child Fetal Neonatal Ed. 2016 Mar;101(2):F127-36. doi: 10.1136/archdischild-2014-307312. Epub 2015 Aug 17. Review.

PMID:
26283668
21.

Parental education and the WHO neonatal G-6-PD screening program: a quarter century later.

Kaplan M, Hammerman C, Bhutani VK.

J Perinatol. 2015 Oct;35(10):779-84. doi: 10.1038/jp.2015.77. Epub 2015 Jul 16. Review.

PMID:
26181718
22.

Glucose-6-Phosphate Dehydrogenase Screening in Israel-Arab and Palestinian-Arab Neonates.

Abu Omar R, Algur N, Megged O, Hammerman C, Kaplan M.

J Pediatr. 2015 Jul;167(1):169-72. doi: 10.1016/j.jpeds.2015.04.039. Epub 2015 Jun 5.

PMID:
25979319
23.

Population-based trends in mortality and neonatal morbidities among singleton, very preterm, very low birth weight infants over 16 years.

Grisaru-Granovsky S, Reichman B, Lerner-Geva L, Boyko V, Hammerman C, Samueloff A, Schimmel MS; Israel Neonatal Network.

Early Hum Dev. 2014 Dec;90(12):821-7. doi: 10.1016/j.earlhumdev.2014.08.009. Epub 2014 Oct 20.

PMID:
25463827
24.

Direct antiglobulin titer strength and hyperbilirubinemia.

Kaplan M, Hammerman C, Vreman HJ, Wong RJ, Stevenson DK.

Pediatrics. 2014 Nov;134(5):e1340-4. doi: 10.1542/peds.2014-1290. Epub 2014 Oct 20.

PMID:
25332496
25.

Hyperbilirubinemia, hemolysis, and increased bilirubin neurotoxicity.

Kaplan M, Bromiker R, Hammerman C.

Semin Perinatol. 2014 Nov;38(7):429-37. doi: 10.1053/j.semperi.2014.08.006. Epub 2014 Oct 3. Review.

PMID:
25284470
26.

Heme oxygenase-1 promoter polymorphisms and neonatal jaundice.

Kaplan M, Renbaum P, Hammerman C, Vreman HJ, Wong RJ, Stevenson DK.

Neonatology. 2014;106(4):323-9. doi: 10.1159/000365744. Epub 2014 Oct 1.

PMID:
25277974
27.

The effects of maternal age and parity on maternal and neonatal outcome.

Schimmel MS, Bromiker R, Hammerman C, Chertman L, Ioscovich A, Granovsky-Grisaru S, Samueloff A, Elstein D.

Arch Gynecol Obstet. 2015 Apr;291(4):793-8. doi: 10.1007/s00404-014-3469-0. Epub 2014 Sep 17.

PMID:
25227657
28.

Rapid fecal calprotectin (FC) analysis: point of care testing for diagnosing early necrotizing enterocolitis.

Bin-Nun A, Booms C, Sabag N, Mevorach R, Algur N, Hammerman C.

Am J Perinatol. 2015 Mar;32(4):337-42. doi: 10.1055/s-0034-1384640. Epub 2014 Aug 11.

PMID:
25111039
29.

Hyperbilirubinemia in black infants.

Kaplan M, Hammerman C.

J Pediatr. 2013 Aug;163(2):611. doi: 10.1016/j.jpeds.2013.04.068. Epub 2013 Jun 14. No abstract available.

PMID:
23751760
30.

Association between neonatal hyperbilirubinemia and UDP-glucuronosyltransferase 1A1 gene polymorphisms.

Kaplan M, Hammerman C.

Pediatr Int. 2013 Apr;55(2):259. doi: 10.1111/ped.12065. No abstract available.

PMID:
23679172
31.

Twin pregnancy in a patient after the Fontan operation: report of a case.

Nir A, Elchalal U, Hammerman C, Rein AJ.

Congenit Heart Dis. 2013 Nov-Dec;8(6):E196-8. doi: 10.1111/chd.12054. Epub 2013 Mar 20.

PMID:
23510330
32.

Correlation of bacterial type and antibiotic sensitivity with maternal antibiotic exposure in early-onset neonatal sepsis.

Bromiker R, Ernest N, Meir MB, Kaplan M, Hammerman C, Schimmel MS, Schlesinger Y.

Neonatology. 2013;103(1):48-53. doi: 10.1159/000342215. Epub 2012 Oct 18. Erratum in: Neonatology. 2013;103(1):53.

PMID:
23095252
33.

Neonatal hyperbilirubinemia in the low-intermediate-risk category on the bilirubin nomogram.

Bromiker R, Bin-Nun A, Schimmel MS, Hammerman C, Kaplan M.

Pediatrics. 2012 Sep;130(3):e470-5. doi: 10.1542/peds.2012-0005. Epub 2012 Aug 27.

PMID:
22926183
34.

Intermediate values of glucose-6-phosphate dehydrogenase.

Kaplan M, Algur N, Hammerman C.

J Pediatr. 2012 Sep;161(3):571; author reply 571-2. doi: 10.1016/j.jpeds.2012.05.064. Epub 2012 Jul 13. No abstract available.

PMID:
22795224
35.

Sucking improvement following blood transfusion for anemia of prematurity.

Bromiker R, Kasinetz Y, Kaplan M, Hammerman C, Schimmel M, Medoff-Cooper B.

Arch Pediatr Adolesc Med. 2012 Oct;166(10):897-901.

PMID:
22664924
36.

Quantitative neonatal glucose-6-phosphate dehydrogenase screening: distribution, reference values, and classification by phenotype.

Algur N, Avraham I, Hammerman C, Kaplan M.

J Pediatr. 2012 Aug;161(2):197-200. doi: 10.1016/j.jpeds.2012.02.045. Epub 2012 Apr 10.

PMID:
22494872
37.

Managing the patent ductus arteriosus in the premature neonate: a new look at what we thought we knew.

Hammerman C, Bin-Nun A, Kaplan M.

Semin Perinatol. 2012 Apr;36(2):130-8. doi: 10.1053/j.semperi.2011.09.023. Review.

PMID:
22414884
38.

Pharmacokinetics of oral ibuprofen for patent ductus arteriosus closure in preterm infants.

Amitai Y, Hammerman C.

Arch Dis Child Fetal Neonatal Ed. 2012 Jan;97(1):F76. doi: 10.1136/fetalneonatal-2011-301204. Epub 2011 Nov 16. No abstract available.

PMID:
22090351
39.

Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment.

Hammerman C, Bin-Nun A, Markovitch E, Schimmel MS, Kaplan M, Fink D.

Pediatrics. 2011 Dec;128(6):e1618-21. doi: 10.1542/peds.2011-0359. Epub 2011 Nov 7.

PMID:
22065264
40.

Mortality and morbidity in preterm small-for-gestational-age infants: a population-based study.

Grisaru-Granovsky S, Reichman B, Lerner-Geva L, Boyko V, Hammerman C, Samueloff A, Schimmel MS; Israel Neonatal Network.

Am J Obstet Gynecol. 2012 Feb;206(2):150.e1-7. doi: 10.1016/j.ajog.2011.08.025. Epub 2011 Aug 27.

PMID:
21982023
41.

Severe neonatal hyperbilirubinemia and kernicterus: are these still problems in the third millennium?

Kaplan M, Bromiker R, Hammerman C.

Neonatology. 2011;100(4):354-62. doi: 10.1159/000330055. Epub 2011 Oct 3. Review.

42.

Neonatal screening for glucose-6-phosphate dehydrogenase deficiency: biochemical versus genetic technologies.

Kaplan M, Hammerman C.

Semin Perinatol. 2011 Jun;35(3):155-61. doi: 10.1053/j.semperi.2011.02.010. Review.

PMID:
21641489
43.

Safety assessment of probiotics for human use.

Sanders ME, Akkermans LM, Haller D, Hammerman C, Heimbach J, Hörmannsperger G, Huys G, Levy DD, Lutgendorff F, Mack D, Phothirath P, Solano-Aguilar G, Vaughan E.

Gut Microbes. 2010 May-Jun;1(3):164-85. doi: 10.4161/gmic.1.3.12127. Epub 2010 Mar 4. Review.

44.

Hemolysis and hyperbilirubinemia in antiglobulin positive, direct ABO blood group heterospecific neonates.

Kaplan M, Hammerman C, Vreman HJ, Wong RJ, Stevenson DK.

J Pediatr. 2010 Nov;157(5):772-7. doi: 10.1016/j.jpeds.2010.05.024. Epub 2010 Jul 2.

45.

The incidence of congenital heart defects in very low birth weight and extremely low birth weight infants.

Godfrey M, Schimmel MS, Hammerman C, Farber B, Glaser J, Nir A.

Isr Med Assoc J. 2010 Jan;12(1):36-8.

46.

N-terminal pro-B-type natriuretic peptide as a marker of bronchopulmonary dysplasia in premature infants.

Joseph L, Nir A, Hammerman C, Goldberg S, Ben Shalom E, Picard E.

Am J Perinatol. 2010 May;27(5):381-6. doi: 10.1055/s-0029-1243312. Epub 2009 Dec 11.

PMID:
20013606
47.

Glucose-6-phosphate dehydrogenase deficiency and severe neonatal hyperbilirubinemia: a complexity of interactions between genes and environment.

Kaplan M, Hammerman C.

Semin Fetal Neonatal Med. 2010 Jun;15(3):148-56. doi: 10.1016/j.siny.2009.10.007. Epub 2009 Nov 26. Review.

PMID:
19942489
48.

N-terminal-pro-B-type natriuretic peptide in premature patent ductus arteriosus: a physiologic biomarker, but is it a clinical tool?

Hammerman C, Shchors I, Schimmel MS, Bromiker R, Kaplan M, Nir A.

Pediatr Cardiol. 2010 Jan;31(1):62-5. doi: 10.1007/s00246-009-9568-1. Epub 2009 Oct 27.

PMID:
19859762
49.

The need for neonatal glucose-6-phosphate dehydrogenase screening: a global perspective.

Kaplan M, Hammerman C.

J Perinatol. 2009 Feb;29 Suppl 1:S46-52. doi: 10.1038/jp.2008.216.

PMID:
19177059
50.

Failure to predict hemolysis and hyperbilirubinemia by IgG subclass in blood group A or B infants born to group O mothers.

Kaplan M, Na'amad M, Kenan A, Rudensky B, Hammerman C, Vreman HJ, Wong RJ, Stevenson DK.

Pediatrics. 2009 Jan;123(1):e132-7. doi: 10.1542/peds.2008-2617. Epub 2008 Dec 29.

PMID:
19114458

Supplemental Content

Loading ...
Support Center